1. Clinicaltrials.gov 2010 A long term study of sibutramine and the role of obesity management in relation to cardiovascular disease in overweight and obese patients (SCOUT)
2. SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects;James;New England Journal of Medicine,2010
3. Sherry , B. Blanck , H. M. Galuska , D. A. Pan , L. Dietz , H. W. Balluz , L. 2010 Vital signs: State-Specific obesity prevalence among adults - United States Morbidity and Mortality Weekly Reviews http://www.cdc.gov/mmwr/pdf/wk/mm59e0803.pdf
4. U.S. Food and Drug Administration 2010a Postmarket drug safety information-- Fen-Phen http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm179871.htm